Abstract
Growth of the human squamous cervical carcinoma cell line, HOG‐1, was stimulated in response to oestradiol in serum‐containing and chemically defined medium. The oestradiol‐stimulated growth could be inhibited by 4‐OH tamoxifen, progesterone and medroxyprogesterone acetate; the last 2 compounds also inhibited basal cell growth in serum‐containing and chemically defined media. The data are consistent with the sensitivity of human squamous cervical cancer to sex‐steroid hormones and suggest that endocrine therapies may be of benefit in this disease. © 1992 Wiley‐Liss, Inc.
| Original language | English (UK) |
|---|---|
| Pages (from-to) | 247-251 |
| Number of pages | 5 |
| Journal | International Journal of Cancer |
| Volume | 52 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - 9 Sept 1992 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'The human squamous cervical carcinoma cell line, HOG‐1, is responsive to steroid hormones'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver